1899年，美国新泽西州 ， 默沙东制药出版了一本 192页的小册子——《默沙东诊疗手册》。 从 AQ 到 "阿福 "， 不仅是 名字 更迭 ， 更标志 着 产品逻辑的根本性转变：从一个 健康 工具，进化为一个 懂 用户 、能主动关怀、 会 追问 、 能 直 连 解决 方案 的有温度的 AI健康朋友。 新版 App 上线后 迅速 攀升 至 苹果 应用 商店 前列， 并 于 今天下午 冲 到 免费 下载 榜 第 2 位。 市场的 热烈 反响 ， 印证了 " 阿福 " 切实 击中 了 用户 需求 。 这 也 让我们看到， 在 中国，当 AI技术应用与实际场景深度结合，会爆发出怎样的想象力。在 这场 全球 AI 竞赛 中 ，中国正在走出一条 注重 实用 、 扎根场景的 "应用 创新 " 之 路。 对于大多数人来说，健康管理最难的不是 "看病"，而是 长期的 "康复"和"预防" 。 阿福新上线的 "健康陪伴"功能，正是为了 弥合 这个断层 。 笔者最近对此深有体会。 在听诊器刚刚普及、抗生素尚未发明的年代，这本书成为了医生和家庭获取医学知识的标准载体。 一百多年来，人类对健康知识的渴求从未改变 ， 变化的 只是 载体 ...

来源：外参财观 12月15日，轻松健康集团正式启动招股，这意味着他们成功闯关港股IPO。 轻松健康的前身是轻松筹，虽然起步比较早，不过随后他们很快被水滴公司实现了反超，甚至还开始面临流量红利见顶的困境。 这第二支撑还是铁打的流水。虽然前几年面临着一定的增长瓶颈，不过这两年轻松健康集团整体的财务数据在逐步好转，甚至可以用"V型"反转来形容。 2022-2024年，轻松健康的收入复合增长率高达54.9%。2025年上半年就更恐怖了，实现了6.56亿元的收入，同比增长84.7%。与此同时，轻松健康2025年 上半年经调整净利润5118万元，同比增长11.3%，现金流还算比较健康。 这第三大支撑离不开强大的股东阵营。轻松健康集团背后拥有IDG资本、腾讯、阳光保险等投资大佬和互联网巨头，能够同时得到众多行业大佬的认可， 这无疑也从侧面验证了轻松健康的未来前景和商业模式，同时也给港股的投资者们吃了一颗定心丸。 不过，轻松健康集团虽然过会了，并不代表他们从此高枕无忧了。 于是，轻松健康集团开启了一场赴港IPO自救运动，并且果断切割了"包袱"，他们将自身业务争议较大的"大病筹款从上市主体中剥离，从而成功实现了 IPO过会。 ...

12月15日，"阿福"火了。 当日，蚂蚁集团旗下AI健康应用AQ正式升级为"蚂蚁阿福"并发布新版App，推出健康陪伴、健康问答、健康服务三大功能，也因此，正式完成从功能性工 具到陪伴型服务的转型。 月活突破1500万、居国内AI应用前五，有人说，这是用户对健康服务"专业+便捷"的真实需求投射，也暗藏着蚂蚁AI战略在健康领域纵深布局的关键落子。 最大的变化：新增健康陪伴 AQ，为什么要改名叫"阿福"？ "可能是因为朗朗上口？""就像来财一样，阿福也寓意着福气"……蚂蚁官宣之前，原来的AQ就已经预告了新版本：全面升级为蚂蚁阿福，对于这个名字， 随即引来不少人士诸多讨论。 当日，蚂蚁集团副总裁、健康事业群总裁张俊杰介绍了"阿福"的寓意：健康是福，健康的事找阿福。他进一步介绍，不仅于医疗，阿福要像医生朋友、私人 营养师、运动教练那样，真的能一对一地和用户对话，不是泛泛而谈，而是一人一策、量身定制。 为实现这一计划，新版阿福有了一个最大的变化，增加了健康陪伴的功能板块。 首先，用户可以通过首页的"健康小日记"模块记录自己的健康状况。目前，阿福开放接入了苹果、华为、vivo、鱼跃、欧姆龙等九大品牌智能设备，用户绑 定设备 ...

从AQ到"阿福"：不至于更名，是体验重构 张俊杰说，给AI应用取名"阿福"寓意"健康是福"，希望用户健康的事就找阿福。 在"AI First"核心战略驱动下，蚂蚁又在AI健康领域落下了关键一子。 12月15日，蚂蚁集团宣布，旗下AI健康应用AQ品牌升级为"蚂蚁阿福"，并发布App新版本，重点升级 健康陪伴、健康问答、健康服务三大功能。 品牌升级同时伴随着亮眼的数据增长：全新"蚂蚁阿福"App已实现月活用户超1500万，稳居国内AI热门 APP，每天回答用户超500万个健康提问。 "从AQ升级到阿福，也是从AI工具升级到AI朋友的过程。"蚂蚁集团副总裁、健康事业群总裁张俊杰在 发布会上阐释了升级背后的演进过程。在这背后，作为AI健康领域的大厂代表，蚂蚁正驱动行业从工 具能力，迈向更深入的全链路服务比拼。 记者了解到，新版"阿福"最大的变化，是增加了健康陪伴的功能板块，用户可以通过首页的"健康小日 记"模块，记录自己的健康状况。 目前，阿福开放接入了苹果、华为、vivo、鱼跃、欧姆龙等九大智能设备。除了智能设备，也能通过拍 照、图片上传的方式做记录，部分地区甚至可以授权后将过往就诊、体检报告一键导入，由阿福归档整 ...

Core Viewpoint - Ant Group has upgraded its AI health application from AQ to "Ant Afu," emphasizing a shift from an AI tool to an AI companion, reflecting the company's strategy to deepen its service capabilities in the health sector [1][7]. Summary by Sections Brand Upgrade and User Engagement - The newly branded "Ant Afu" app has achieved over 15 million monthly active users and answers more than 5 million health-related questions daily, establishing itself as a leading AI health app in China [1][5]. - The upgrade includes features like health journaling, personalized health goals, and reminders, enhancing user engagement and interaction [2][5]. Service Capabilities - "Ant Afu" connects with over 5,000 hospitals and 300,000 real doctors, providing a seamless service from problem identification to appointment booking and insurance payment [4][8]. - The app's ability to interpret health reports and recognize common skin conditions through photo uploads demonstrates its advanced service capabilities [5][8]. Market Demand and Growth Potential - The health-related search queries on Baidu exceed 200 million daily, indicating a robust demand for health services, particularly from users in lower-tier cities [5]. - The health industry in China is projected to reach nearly 9 trillion yuan by 2024, highlighting the significant growth potential for AI health applications [5]. Strategic Positioning - Ant Group's "AI First" strategy focuses on deepening its presence in the health sector, which is characterized by high demand and trust, setting it apart from competitors [7][8]. - The company aims to leverage its decade-long experience in the health sector, including established connections with hospitals and a trust system in medical insurance, to create a complex barrier to entry for competitors [8]. Challenges and Future Directions - Transitioning from a tool to a companion requires balancing professional knowledge and user-friendly design, posing challenges in service effectiveness [10]. - The focus is shifting towards measurable service outcomes rather than just technical capabilities, marking a new phase in AI health applications [10].

【环球网科技报道 记者 李文瑶】12月15日，蚂蚁集团正式宣布将其旗下AI健康应用AQ升级为"蚂蚁阿福"，并完成品牌与功能双重焕新。此次升级不仅是名 称的更迭，更标志着蚂蚁在数字健康赛道的战略重心从"医疗AI工具"向"AI健康朋友"的系统性转移。新版"阿福"App聚焦"健康+"战略，月活跃用户已突破 1500万，跻身国内AI应用前五，并成为用户规模最大的健康管理类AI应用。 蚂蚁集团副总裁、健康事业群总裁张俊杰表示，"阿福"取意"健康是福"，旨在成为用户随时可寻的健康伙伴。此次升级的核心是从功能型工具转向陪伴型朋 友，通过"健康陪伴、健康问答、健康服务"三大功能板块的深化，构建覆盖日常健康管理、专业咨询与医疗资源连接的一体化服务平台。 战略转身：从工具到 " 朋友 " ，掘金健康管理中间地带 月活超1500万的数据，使阿福在国内AI应用阵营中稳居前列。更值得关注的是其用户结构：55%的用户来自三线及以下城市。这反映出阿福在基层市场较强 的穿透力，与"健康中国"战略中强化基层健康服务的导向形成呼应。 这一转型与行业趋势紧密契合。随着公众健康意识提升和智能设备普及，健康管理的范畴正从"治病"加速前移至"防病"和" ...

凤凰网科技讯 12月15日，凤凰网科技获悉，蚂蚁集团旗下AI健康应用蚂蚁AQ更名为"蚂蚁阿福"，并发 布App新版本，升级健康陪伴、健康问答、健康服务三个功能。 据其官方表述，升级后的"蚂蚁阿福"聚焦"健康+"战略，定位从AI工具转向AI健康朋友，目标是"像真人 朋友一样"，帮助用户管理自身和家人健康。 据披露，目前"蚂蚁阿福"App的月活用户已超1500万，成为第一大健康管理AI App。据了解，目前阿福 APP每天回答用户500多万个健康提问，55%用户来自三线及以下城市。 ...

责任编辑：江钰涵 新浪科技讯 12月15日下午消息，今日，蚂蚁集团宣布旗下AI健康应用AQ品牌升级为"蚂蚁阿福"，并发 布App新版本，升级健康陪伴、健康问答、健康服务三大功能。升级后的"蚂蚁阿福"聚焦"健康+"战 略，定位从AI工具转向AI健康朋友，能够像真人朋友一样，帮助用户管理自身和家人健康，实现专业 全能、私人专属、服务丰富的优势。 新浪科技讯 12月15日下午消息，今日，蚂蚁集团宣布旗下AI健康应用AQ品牌升级为"蚂蚁阿福"，并发 布App新版本，升级健康陪伴、健康问答、健康服务三大功能。升级后的"蚂蚁阿福"聚焦"健康+"战 略，定位从AI工具转向AI健康朋友，能够像真人朋友一样，帮助用户管理自身和家人健康，实现专业 全能、私人专属、服务丰富的优势。 目前，"蚂蚁阿福"App的月活用户已超1500万，跻身国内AI App前五，成为第一大健康管理AI App。据 了解，目前阿福APP每天回答用户500多万个健康提问，55%用户来自三线及以下城市，普惠特点明 显。 蚂蚁集团副总裁、健康事业群总裁张俊杰介绍说，取名"阿福"寓意健康是福，健康的事就找阿福。新 版"阿福"最大的变化，是增加了健康陪伴的功能板块 ...

Core Insights - Function Health is addressing the challenge of translating vast health data into actionable insights for individuals, aiming to bridge the gap between health data and actual health improvement [2] - The company completed a $298 million Series B funding round in November 2025, achieving a post-money valuation of $2.5 billion, a 13-fold increase from its previous valuation in June 2024 [2][4] - Function Health's mission is to empower individuals to manage their health proactively, with a goal of enabling everyone to live healthily until the age of 100 [9][12] Funding and Investment - The Series B funding round was led by prominent investors including Redpoint Ventures and Andreessen Horowitz, alongside notable figures from the tech and entertainment industries [3][4] - Cumulative funding for Function Health has reached $350 million, indicating strong investor confidence in its business model and growth potential [2] Product Development and Innovation - Function Health offers a comprehensive health check that includes over 100 laboratory tests, covering various health domains, which is significantly more extensive than traditional health check-ups [14] - The company has launched the Medical Intelligence Lab (MI Lab), which utilizes AI to analyze health data from various sources, providing personalized health insights and recommendations [15] - Function Health acquired Ezra, an AI medical imaging company, enhancing its capabilities in early cancer detection and significantly reducing the cost and time of full-body MRI scans [16] Market Trends and Growth Potential - The global preventive healthcare market is projected to grow rapidly, with an expected market size of $36.1 billion by 2025 and $65.4 billion by 2030, driven by increasing healthcare costs and an aging population [23] - Chronic diseases account for 75% of global healthcare spending, highlighting the need for early intervention and preventive measures [24] - The shift in focus from selling medical devices to providing insights and ongoing services is a key trend in the industry, indicating a growing demand for personalized healthcare solutions [23] Competitive Landscape - The preventive healthcare market features a mix of established players and emerging startups, with companies like InsideTracker, LetsGetChecked, and Ping An Good Doctor competing in various niches [25][26] - Function Health's unique combination of extensive testing, AI-driven insights, and affordable pricing positions it favorably against competitors, creating a significant competitive moat [21]

Core Insights - Ant Group's CEO, Han Xinyi, emphasized the company's commitment to AI in healthcare, aiming to simplify medical processes and enhance public health [1][5] - The establishment of the health business group marks a strategic pivot for Ant Group, focusing on addressing the growing health demands of the population [1][5] Group 1: Market Demand and AI Solutions - There are over 500 million chronic disease patients in China, with significant issues in awareness, treatment, and management, particularly among the 270 million hypertension patients, where over 80% are not effectively managing their condition [3] - The demand for health services is increasing among the elderly population (over 310 million) and younger generations (post-90s and post-00s), who are becoming the main consumers of health services [3] - Ant Group's AI health application, AQ, launched in June, has surpassed 10 million monthly active users within four months, achieving a compound growth rate of 83.4%, the highest in the industry [3][4] Group 2: AI Application and Healthcare Empowerment - Ant Group is expanding its AI healthcare applications, including a collaboration with Shanghai Renji Hospital to create a urology specialty AI system, which has improved diagnostic accuracy for primary care doctors by 4%-8% [3][4] - The "Digital Family Doctor" AI initiative has been implemented in Shanghai's Huangpu District, serving 400,000 residents and one million professionals [3] - Ant Group has developed over 300 "famous doctor AI avatars" in partnership with top-tier hospitals, significantly increasing access to quality healthcare services for patients across 371 cities [4] Group 3: Chronic Disease Management and Strategic Collaborations - AQ provides personalized management services for over 500 million chronic disease patients through AI health records and integration with smart health devices [4] - Ant Group has formed a strategic partnership with West China Hospital of Sichuan University to enhance research and service systems for chronic diseases, focusing on bridging the gap between AI medical research and clinical application [4]